EUVIMEDEUVIMED entdecken
Crossref

Surgery after endoscopic removal of a malignant polyp: is residual disease a real issue?

A. I. Ferreira, J. Goncalves, M. Marques Souto, S. Xavier, P. Boal Carvalho, J. Magalhães, J. Cotter

Endoscopy · 01.04.2024 · 56 (S 02 S 02) · S379-S380

DOI: 10.1055/s-0044-1783635 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endoscopy, erschienen am 01.04.2024. Verfasst von A. I. Ferreira und 6 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Evaluate factors associated with the presence of residual malignant disease in the surgical specimen after endoscopic removal of a malignant polyp without endoscopic cure.

Methods

Retrospective, cohort study including patients with a malignant polyp endoscopically removed without endoscopic cure, who underwent surgery. The absence of endoscopic cure was defined as positive vertical resection margins ( 1 mm, presence of lymphatic or vascular invasion, or presence of tumour budding. Patients with a synchronous neoplastic lesion and those with a malignant polyp without complete endoscopic removal were excluded.

Results

Included 74 consecutive patients submitted to surgery after the endoscopic removal of a malignant polyp without endoscopic cure. Regarding the endoscopic mucosal resection (EMR), 45 polyps were removed in one fragment (60.8%) and the other 29 were submitted to piecemeal EMR (39.2%). In 15 cases, snare tip spray coagulation (STSC) was performed at the margins of mucosal defects after EMR, 6 in normal-appearing margins (8.1%) and 9 in margins suspected of residual adenomatous tissue (12.2%). Considering the post-operative outcomes, 7 patients required surgical re-intervention (9.5%), 1 was admitted in the intensive care unit (1.4%), 1 patient died (1.4%), and 2 patients required re-hospitalization in the following 6 months (2.7%). The presence of residual malignant disease in the surgical specimen occurred in 9 patients (12.2%), 7 had intramural disease (9.5%) and 2 had nodal metastasis (2.7%). Patients with polyps with a flat component were 5 times more likely to have residual disease in the surgical specimen ( p =0.043). Patients with polyps submitted to piecemeal EMR were 7 times more likely to have residual disease in the surgical specimen ( p =0.024), with 2 patients with residual disease after EMR in one fragment (4.4%) and 7 patients with residual disease from the piecemeal EMR group (24.1%). Those in which STSC was performed were also more likely to have residual disease in the surgical specimen ( p

Zitieren

APA

Ferreira, A. I., Goncalves, J., Souto, M. M., Xavier, S., Carvalho, P. B., Magalhães, J., & Cotter, J. (2024). Surgery after endoscopic removal of a malignant polyp: is residual disease a real issue?. Endoscopy, 56(S 02 S 02), S379-S380. https://doi.org/10.1055/s-0044-1783635

Vancouver

Ferreira AI, Goncalves J, Souto MM, Xavier S, Carvalho PB, Magalhães J, et al. Surgery after endoscopic removal of a malignant polyp: is residual disease a real issue?. Endoscopy. 2024;56(S 02 S 02):S379-S380. doi:10.1055/s-0044-1783635

BibTeX
@article{Ferreira2024,
  author = {Ferreira, A. I. and Goncalves, J. and Souto, M. Marques and Xavier, S. and Carvalho, P. Boal and Magalhães, J. and Cotter, J.},
  title = {Surgery after endoscopic removal of a malignant polyp: is residual disease a real issue?},
  journal = {Endoscopy},
  year = {2024},
  volume = {56},
  number = {S 02 S 02},
  pages = {S379--S380},
  doi = {10.1055/s-0044-1783635}
}
Kostenlos starten →